These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 19602592)
1. Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Mohammad HP; Cai Y; McGarvey KM; Easwaran H; Van Neste L; Ohm JE; O'Hagan HM; Baylin SB Cancer Res; 2009 Aug; 69(15):6322-30. PubMed ID: 19602592 [TBL] [Abstract][Full Text] [Related]
2. DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer. Jin B; Yao B; Li JL; Fields CR; Delmas AL; Liu C; Robertson KD Cancer Res; 2009 Sep; 69(18):7412-21. PubMed ID: 19723660 [TBL] [Abstract][Full Text] [Related]
3. Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription. Nawaz Z; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K Sci Rep; 2016 Jun; 6():27753. PubMed ID: 27291091 [TBL] [Abstract][Full Text] [Related]
4. Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus. Li Q; Wang X; Lu Z; Zhang B; Guan Z; Liu Z; Zhong Q; Gu L; Zhou J; Zhu B; Ji J; Deng D PLoS One; 2010 Oct; 5(10):e13732. PubMed ID: 21060834 [TBL] [Abstract][Full Text] [Related]
5. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer. Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271 [TBL] [Abstract][Full Text] [Related]
6. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1. Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526 [TBL] [Abstract][Full Text] [Related]
7. PcG proteins, DNA methylation, and gene repression by chromatin looping. Tiwari VK; McGarvey KM; Licchesi JD; Ohm JE; Herman JG; Schübeler D; Baylin SB PLoS Biol; 2008 Dec; 6(12):2911-27. PubMed ID: 19053175 [TBL] [Abstract][Full Text] [Related]
8. The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration. Federico A; Sepe R; Cozzolino F; Piccolo C; Iannone C; Iacobucci I; Pucci P; Monti M; Fusco A Biochim Biophys Acta Gene Regul Mech; 2019 Apr; 1862(4):509-521. PubMed ID: 30826432 [TBL] [Abstract][Full Text] [Related]
9. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Gal-Yam EN; Egger G; Iniguez L; Holster H; Einarsson S; Zhang X; Lin JC; Liang G; Jones PA; Tanay A Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12979-84. PubMed ID: 18753622 [TBL] [Abstract][Full Text] [Related]
10. The Polycomb group protein EZH2 directly controls DNA methylation. Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870 [TBL] [Abstract][Full Text] [Related]
13. ATRA inhibits the proliferation of DU145 prostate cancer cells through reducing the methylation level of HOXB13 gene. Liu Z; Ren G; Shangguan C; Guo L; Dong Z; Li Y; Zhang W; Zhao L; Hou P; Zhang Y; Wang X; Lu J; Huang B PLoS One; 2012; 7(7):e40943. PubMed ID: 22808286 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers. Youssef EM; Chen XQ; Higuchi E; Kondo Y; Garcia-Manero G; Lotan R; Issa JP Cancer Res; 2004 Apr; 64(7):2411-7. PubMed ID: 15059893 [TBL] [Abstract][Full Text] [Related]
15. Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes. Reddington JP; Perricone SM; Nestor CE; Reichmann J; Youngson NA; Suzuki M; Reinhardt D; Dunican DS; Prendergast JG; Mjoseng H; Ramsahoye BH; Whitelaw E; Greally JM; Adams IR; Bickmore WA; Meehan RR Genome Biol; 2013 Mar; 14(3):R25. PubMed ID: 23531360 [TBL] [Abstract][Full Text] [Related]
16. Nonoverlapping functions of the Polycomb group Cbx family of proteins in embryonic stem cells. Morey L; Pascual G; Cozzuto L; Roma G; Wutz A; Benitah SA; Di Croce L Cell Stem Cell; 2012 Jan; 10(1):47-62. PubMed ID: 22226355 [TBL] [Abstract][Full Text] [Related]
17. DNA methylation as a target of epigenetic therapeutics in cancer. Li KK; Li F; Li QS; Yang K; Jin B Anticancer Agents Med Chem; 2013 Feb; 13(2):242-7. PubMed ID: 22934696 [TBL] [Abstract][Full Text] [Related]
18. CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1. Yu T; Wu Y; Hu Q; Zhang J; Nie E; Wu W; Wang X; Wang Y; Liu N Oncotarget; 2017 Apr; 8(16):26637-26647. PubMed ID: 28460453 [TBL] [Abstract][Full Text] [Related]
19. Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing. Wu X; Gong Y; Yue J; Qiang B; Yuan J; Peng X Nucleic Acids Res; 2008 Jun; 36(11):3590-9. PubMed ID: 18460542 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Bracken AP; Dietrich N; Pasini D; Hansen KH; Helin K Genes Dev; 2006 May; 20(9):1123-36. PubMed ID: 16618801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]